Namoxyrate

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C17H18O2.C4H11NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 38IDB6L05D, chemically known as 4-biphenylacetic acid, alpha-ethyl-, compd. with 2-(dimethylamino)ethanol (1:1) but generally known as namoxyrate, which bears US NIH Compound Identifier 14694. European Medicines Agency schedules Namoxyrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09146MIG. The term NAMOXYRATE is an International Non-Proprietary Name. NAMOXYRATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule namoxyrate under HS 29221980 and SITC 51461. As of Q4 2014, NAMOXYRATE remains the US FDA Preferred Term for this commodity. Namoxyrate bears US NLM identifiers UMLS ID C2827272 and NCI Concept Code C83982. SMILES: OC(=O)C(CCC1CCC(CC1)C1CCCCC1)C.OCCN(C)C.